not losing weight on semaglutides Why Am I Semaglutide? Why Am I Not Losing
Description
GLP-1 Medications Linked to Serious Health Complications While GLP-1 receptor agonist drugs such as Ozempic, Wegovy, Rybelsus, and Mounjaro have been widely promoted for their weight loss benefits and ability to treat type 2 diabetes, many patients have reported severe health issues after taking these medications

GLP-1 ID addresses this by removing the fixed schedule entirely

So, while tirzepatide is also a GIP receptor agonist, they have many of the same side effects
/assets/images/provider/photos/2764906.jpg)
If retatrutide produces better weight loss but costs significantly more, NICE may restrict it to specific patient groups while Mounjaro remains the first-line option

It lasts two to seven years

Diarrhea may happen early as the body adjusts